litlas
Log inCreate account

Jong-Seok Lee

Active 1993–2026

Also published as
Jong Seok Lee · Jong‐Seok Lee
458
Papers
50,957
Citations
97
h-index
295
i10-index

Citations

Citations per year for Jong-Seok Lee1971: 1 citations1975: 1 citations1986: 1 citations1995: 4 citations1996: 9 citations1997: 3 citations1998: 7 citations1999: 8 citations2000: 12 citations2001: 17 citations2002: 23 citations2003: 22 citations2004: 21 citations2005: 37 citations2006: 74 citations2007: 64 citations2008: 79 citations2009: 92 citations2010: 99 citations2011: 125 citations2012: 205 citations2013: 280 citations2014: 305 citations2015: 390 citations2016: 661 citations2017: 838 citations2018: 1,003 citations2019: 2,490 citations2020: 2,844 citations2021: 2,732 citations2022: 2,403 citations2023: 2,061 citations2024: 3,037 citations2025: 1,986 citations2026: 215 citations1972–1974: no citations, so these years are not shown1976–1985: no citations, so these years are not shown1987–1994: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 5,721 citing papers, 19.3% of this breakdownUnited States: 5,503 citing papers, 18.6% of this breakdownUnited Kingdom: 1,357 citing papers, 4.6% of this breakdownSouth Korea: 1,348 citing papers, 4.6% of this breakdownJapan: 1,344 citing papers, 4.5% of this breakdownItaly: 1,291 citing papers, 4.4% of this breakdownFrance: 1,138 citing papers, 3.8% of this breakdownGermany: 1,056 citing papers, 3.6% of this breakdownSpain: 966 citing papers, 3.3% of this breakdownIndia: 823 citing papers, 2.8% of this breakdownCanada: 798 citing papers, 2.7% of this breakdownAustralia: 694 citing papers, 2.3% of this breakdown
0%19.3%Other 25.5%

Institutions

Fields

  • Medicine53.3%
  • Computer Science12.8%
  • Neuroscience9.4%
  • Psychology8%
  • Biochemistry, Genetics and Molecular Biology7.4%
  • Immunology and Microbiology2.6%
  • Other6.5%

Topics

  • Cancer Immunotherapy and Biomarkers10%
  • Lung Cancer Treatments and Mutations6.8%
  • Emotion and Mood Recognition4.7%
  • EEG and Brain-Computer Interfaces4.6%
  • Lung Cancer Research Studies4.3%
  • Lung Cancer Diagnosis and Treatment2.8%
  • Other66.8%

Coauthors

All papers

Open in search
  1. DEAP: A Database for Emotion Analysis ;Using Physiological Signals

    Authors: Sander Koelstra, Christian Mühl, Mohammad Soleymani, Jong-Seok Lee, Ashkan Yazdani, Touradj Ebrahimi, Thierry Pun, Anton Nijholt, Ioannis Patras - IEEE Transactions on Affective Computing, IEEE Trans. Affect. Comput. 2011 cited by 4,847

  2. Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer

    Authors: Edward B. Garon, Naiyer A. Rizvi, Rina Hui, Natasha B. Leighl, Ani Sarkis Balmanoukian, Joseph P. Eder, Amita Patnaik, Charu Aggarwal, Matthew A. Gubens, Leora Horn, Enric Carcereny, Myung‐Ju Ahn, Enriqueta Felip, Jong-Seok Lee, Matthew D. Hellmann, Omid Hamid, Jonathan W. Goldman, Jean‐Charles Soria, Marisa Dolled‐Filhart, Ruth Z. Rutledge, Jin Zhang, Jared Lunceford, Reshma Rangwala, Gregory M. Lubiniecki, Charlotte Roach, Kenneth Emancipator, Leena Gandhi - New England Journal of Medicine 2015 cited by 6,228

  3. Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial

    Authors: Achim Rittmeyer, Fabrice Barlési, Daniel Waterkamp, Keunchil Park, Fortunato Ciardiello, Joachim von Pawel, Shirish M. Gadgeel, Toyoaki Hida, Dariusz M. Kowalski, Manuel Cobo, Diego Cortinovis, Joseph W. Leach, Jonathan Polikoff, Carlos H. Barrios, Fairooz F. Kabbinavar, Osvaldo Arén Frontera, Filippo de Marinis, Hande Turna, Jong-Seok Lee, Marcus Ballinger, Marcin Kowanetz, Pei He, Daniel S. Chen, Alan Sandler, David R. Gandara - The Lancet 2016 cited by 4,780

  4. Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB–IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial

    Authors: Mary O’Brien, Luis Paz‐Ares, Sandrine Marréaud, Urania Dafni, Kersti Oselin, Libor Havel, Emilio Esteban, Dolores Isla, Alex Martínez‐Martí, Martin Faehling, Masahiro Tsuboi, Jong Seok Lee, Kazuhiko Nakagawa, Jing Yang, Ayman Samkari, Steven M. Keller, Murielle Mauer, Nitish Jha, Rolf A. Stahel, Benjamin Besse, Solange Peters - The Lancet Oncology 2022 cited by 744

  5. Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer

    Authors: Myung‐Ju Ahn, Byoung Chul Cho, Enriqueta Felip, Ippokratis Korantzis, Kadoaki Ohashi, Margarita Majem, Óscar Juan, Sabin Handzhiev, Hiroki Izumi, Jong Seok Lee, Rafał Dziadziuszko, Jürgen Wolf, Fiona Blackhall, Martin Reck, Jean Bustamante Alvarez, Horst-Dieter Hummel, Anne‐Marie C. Dingemans, Jacob Sands, Hiroaki Akamatsu, Taofeek K. Owonikoko, Suresh S. Ramalingam, Hossein Borghaei, Melissa L. Johnson, Shuang Huang, Sujoy Mukherjee, Mukul Minocha, Tony Jiang, Pablo Martínez, Erik S. Anderson, Luis Paz‐Ares - New England Journal of Medicine 2023 cited by 482

  6. Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)

    Authors: Stephen V. Liu, Martin Reck, Aaron S. Mansfield, Tony Mok, Arnaud Scherpereel, Niels Reinmuth, Marina Chiara Garassino, Javier de Castro, Raffaele Califano, Makoto Nishio, Francesco Orlandi, Jorge Alatorre-Alexander, Ticiana Leal, Ying Cheng, Jong Seok Lee, Sivuonthanh Lam, Mark L. McCleland, Yu Deng, See Phan, Leora Horn - Journal of Clinical Oncology 2021 cited by 824

  7. Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden

    Authors: Matthew D. Hellmann, Tudor–Eliade Ciuleanu, Adam Płużański, Jong Seok Lee, Gregory A. Otterson, Clarisse Audigier-Valette, Elisa Minenza, Helena Linardou, Sjaak A. Burgers, Pamela Salman, Hossein Borghaei, Suresh S. Ramalingam, Julie R. Brahmer, Martin Reck, Kenneth J. O’Byrne, William J. Geese, George Green, Chang Han, Joseph D. Szustakowski, Prabhu Bhagavatheeswaran, Diane Healey, Yali Fu, Faith E. Nathan, Luis Paz‐Ares - New England Journal of Medicine 2018 cited by 3,137

  8. Single-Agent Divarasib (GDC-6036) in Solid Tumors with a KRAS G12C Mutation

    Authors: Adrian G. Sacher, Patricia LoRusso, Manish R. Patel, Wilson H. Miller, Elena Garralda, Martin Förster, Armando Santoro, Alejandro Falcón, Tae Won Kim, Luis Paz‐Ares, Samantha Bowyer, Maria de Miguel, Sae‐Won Han, Matthew Krebs, Jong Seok Lee, Michael L. Cheng, Kathryn C. Arbour, Erminia Massarelli, Yoonha Choi, Zhen Shi, Sandhya Mandlekar, Mark T. Lin, Stephanie Royer‐Joo, Julie Chang, Neekesh V. Dharia, Jennifer L. Schutzman, Jayesh Desai - New England Journal of Medicine 2023 cited by 294

  9. Amivantamab in EGFR Exon 20 Insertion–Mutated Non–Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study

    Authors: Keunchil Park, Eric B. Haura, Natasha B. Leighl, Paul Mitchell, Catherine A. Shu, Nicolas Girard, Santiago Viteri, Ji‐Youn Han, Sang‐We Kim, Chee Khoon Lee, Joshua K. Sabari, Alexander I. Spira, Tsung‐Ying Yang, Dong‐Wan Kim, Ki Hyeong Lee, Rachel E. Sanborn, José Trigo, Kōichi Goto, Jong‐Seok Lee, James Chih‐Hsin Yang, Ramaswamy Govindan, Joshua Bauml, Pilar Garrido, Matthew Krebs, Karen L. Reckamp, John Xie, Joshua C. Curtin, Nahor Haddish‐Berhane, Amy Roshak, Dawn Millington, Patricia Lorenzini, Meena Thayu, Roland E. Knoblauch, Byoung Chul Cho - Journal of Clinical Oncology 2021 cited by 632

  10. Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non–Small-Cell Lung Cancer in CheckMate 227

    Authors: Julie R. Brahmer, Jong-Seok Lee, Tudor–Eliade Ciuleanu, Reyes Bernabe Caro, Makoto Nishio, László Urbán, Clarisse Audigier-Valette, Lorena Lupinacci, Randeep Sangha, Adam Płużański, Jacobus A. Burgers, Mauricio Mahave, Samreen Ahmed, Adam J. Schoenfeld, Luis Paz‐Ares, Martin Reck, Hossein Borghaei, Kenneth J. O’Byrne, Ravi G. Gupta, Judith Bushong, Li Li, Steven I. Blum, Laura J. Eccles, Suresh S. Ramalingam - Journal of Clinical Oncology 2022 cited by 381

  11. Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial

    Authors: Jonathan W. Goldman, Mikhail Dvorkin, Yuanbin Chen, Niels Reinmuth, Katsuyuki Hotta, Dmytro Trukhin, Galina Statsenko, Maximilian J. Hochmair, Mustafa Özgüroğlu, Jun Ho Ji, Marina Chiara Garassino, Олександр Войтко, Artem Poltoratskiy, Santiago Ponce, Francesco Verderame, Libor Havel, Igor Bondarenko, Andrzej Każarnowicz, György Losonczy, Nikolay Conev, J. Armstrong, Natalie Byrne, Piruntha Thiyagarajah, Haiyi Jiang, Luis Paz‐Ares, Mikhail Dvorkin, Dmytro Trukhin, Galina Statsenko, Nataliia Voitko, Artem Poltoratskiy, Igor Bondarenko, Yuanbin Chen, Andrzej Każarnowicz, Luis Paz‐Ares, Mustafa Özgüroğlu, Nikolay Conev, Maximilian J. Hochmair, Otto C. Burghuber, Libor Havel, İrfan Çiçin, György Losonczy, В. Моисеенко, Mustafa Erman, Dariusz M. Kowalski, Marek Z. Wojtukiewicz, Hryhoriy Adamchuk, Alexander Vasilyev, Serhii Shevnia, Spartak Valev, Niels Reinmuth, Jun Ho Ji, Maria Amelia Insa Molla, Grygorii Ursol, Anne C. Chiang, Sylvia Hartl, Zsolt Horváth, Gábor Pajkos, Francesco Verderame, Katsuyuki Hotta, Sang‐We Kim, Alexey Smolin, Tuncay Göksel, Shaker R. Dakhil, Jaromı́r Roubec, Krisztina Bogos, Marina Chiara Garassino, Robin Cornelissen, Jong-Seok Lee, M.R. García Campelo, Marta López Brea, Ahmet Alacacıoğlu, Ignacio Casarini, Rumyana Ilieva, Ivan Tonev, A Somfay, Jair Bar, Alona Zer Kuch, Mauro Minelli, Roberta Bartolucci, Fausto Roila, Haruhiro Saito, Koichi Azuma, Gyeong‐Won Lee, Alexander Luft, Michal Urda, Juan Ignacio Delgado Mingorance, M. Majem Tarruella, David R. Spigel, Krassimir Koynov, Milada Zemanová, Jens Panse, Christian Schulz, Zsolt Pápai Székely, Veronika Sárosi, Angelo Delmonte, Anna Bettini, Makoto Nishio, Isamu Okamoto, Lizza Hendriks, Sławomir Mańdziuk and 153 more - The Lancet Oncology 2020 cited by 687

  12. Brigatinib versus Crizotinib in ALK -Positive Non–Small-Cell Lung Cancer

    Authors: D. Ross Camidge, Hye Ryun Kim, Myung‐Ju Ahn, James Chih‐Hsin Yang, Ji‐Youn Han, Jong Seok Lee, Maximilian J. Hochmair, Jacky Yu-Chung Li, Gee‐Chen Chang, Ki Hyeong Lee, Cesare Gridelli, Angelo Delmonte, Rosario García Campelo, Dong‐Wan Kim, Alessandra Bearz, Frank Griesinger, Alessandro Morabito, Enriqueta Felip, Raffaele Califano, Sharmistha Ghosh, Alexander I. Spira, Scott Gettinger, Marcello Tiseo, Neeraj Gupta, J. Haney, David Kerstein, Sanjay Popat - New England Journal of Medicine 2018 cited by 976

  13. Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC

    Authors: Byoung Chul Cho, Shun Lu, Enriqueta Felip, Alexander I. Spira, Nicolas Girard, Jong-Seok Lee, Se-Hoon Lee, Yurii Ostapenko, Pongwut Danchaivijitr, Baogang Liu, Adlinda Alip, Ernesto Korbenfeld, Josiane Mourão Dias, Benjamin Besse, Ki-Hyeong Lee, Hailin Xiong, Soon-Hin How, Ying Cheng, Gee‐Chen Chang, Hiroshige Yoshioka, James Chih‐Hsin Yang, Michael J. Thomas, Danny Nguyen, Sai‐Hong Ignatius Ou, Sanjay Mukhedkar, Kumar Prabhash, M. D’Arcangelo, Jorge Alatorre-Alexander, Juan Carlos Vázquez Limón, Sara Alves, Daniil Stroyakovskiy, Marina Peregudova, Mehmet Alı Nahıt Şendur, Ozan Yazıcı, Raffaele Califano, Vanesa Gutiérrez Calderón, Filippo de Marinis, Antonio Passaro, Sang‐We Kim, Shirish M. Gadgeel, John Xie, Tao Sun, Melissa Martínez, Mariah Ennis, E. Fennema, Mahesh Daksh, Dawn Millington, Isabelle Leconte, Ryota Iwasawa, Patricia Lorenzini, Mahadi Baig, Sujay Shah, Joshua Bauml, S. Martin Shreeve, Seema Sethi, R.E. Knoblauch, Hidetoshi Hayashi - New England Journal of Medicine 2024 cited by 375

  14. Artificial Intelligence–Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non–Small-Cell Lung Cancer

    Authors: Sehhoon Park, Chan‐Young Ock, Hyojin Kim, Sérgio Pereira, Seonwook Park, Minuk Ma, Sangjoon Choi, Seokhwi Kim, Seunghwan Shin, Brian Jaehong Aum, Kyunghyun Paeng, Donggeun Yoo, Hongui Cha, Sunyoung Park, Koung Jin Suh, Hyun Ae Jung, Se Hyun Kim, Yu Jung Kim, Jong‐Mu Sun, Jin-Haeng Chung, Jin Seok Ahn, Myung‐Ju Ahn, Jong Seok Lee, Keunchil Park, Sang Yong Song, Yung‐Jue Bang, Yoon‐La Choi, Tony Mok, Se‐Hoon Lee - Journal of Clinical Oncology 2022 cited by 282

  15. Alectinib in Resected ALK -Positive Non–Small-Cell Lung Cancer

    Authors: Yi‐Long Wu, Rafał Dziadziuszko, Jin Seok Ahn, Fabrice Barlési, Makoto Nishio, Ki Hyeong Lee, Jong Seok Lee, Wen‐Zhao Zhong, Hidehito Horinouchi, Weimin Mao, Maximilian J. Hochmair, Filippo de Marinis, M.R. Migliorino, Igor Bondarenko, Shun Lü, Qun Wang, Tania Ochi Lohmann, Tingting Xu, Andrés F. Cardona, Thorsten Ruf, Johannes Noé, Benjamin Solomon - New England Journal of Medicine 2024 cited by 382

  16. First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 Trial

    Authors: Luis Paz‐Ares, Suresh S. Ramalingam, Tudor–Eliade Ciuleanu, Jong-Seok Lee, László Urbán, Reyes Bernabe Caro, Keunchil Park, Hiroshi Sakai, Yuichiro Ohe, Makoto Nishio, Clarisse Audigier-Valette, Jacobus A. Burgers, Adam Płużański, Randeep Sangha, Carlos Gallardo, Masayuki Takeda, Helena Linardou, Lorena Lupinacci, Ki Hyeong Lee, Claudia Caserta, Mariano Provencio, Enric Carcereny, Gregory A. Otterson, Michael Schenker, Bogdan Żurawski, Aurelia Alexandru, A. Vergnenègre, Judith Raimbourg, Kynan Feeney, Sang‐We Kim, Hossein Borghaei, Kenneth J. O’Byrne, Matthew D. Hellmann, Arteid Memaj, Faith E. Nathan, Judith Bushong, Phuong Tran, Julie R. Brahmer, Martin Reck - Journal of Thoracic Oncology 2021 cited by 322

  17. Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas

    Authors: Jake June-Koo Lee, Junehawk Lee, Sehui Kim, Soyeon Kim, Jeonghwan Youk, Seongyeol Park, Yohan An, Bhumsuk Keam, Dong‐Wan Kim, Dae Seog Heo, Young Tae Kim, Jin-Soo Kim, Se Hyun Kim, Jong Seok Lee, Se‐Hoon Lee, Keunchil Park, Ja‐Lok Ku, Yoon Kyung Jeon, Doo Hyun Chung, Peter J. Park, Joon Kim, Tae‐Min Kim, Young Seok Ju - Journal of Clinical Oncology 2017 cited by 508

  18. Osimertinib + Savolitinib to Overcome Acquired MET-Mediated Resistance in Epidermal Growth Factor Receptor–Mutated, MET -Amplified Non–Small Cell Lung Cancer: TATTON

    Authors: Ryan J. Hartmaier, Aleksandra Markovets, Myung‐Ju Ahn, Lecia V. Sequist, Ji‐Youn Han, Byoung Chul Cho, Helena A. Yu, Sang‐We Kim, James Chih‐Hsin Yang, Jong Seok Lee, Wu‐Chou Su, Dariusz M. Kowalski, С. В. Орлов, Song Ren, Paul Frewer, Xiaoling Ou, Darren A.E. Cross, Nisha Kurian, Mireille Cantarini, Pasi A. Jänne - Cancer Discovery 2022 cited by 154

  19. NTIRE 2018 Challenge on Single Image Super-Resolution: Methods and Results

    Authors: Radu Timofte, Shuhang Gu, Jiqing Wu, Luc Van Gool, Lei Zhang, Shuicheng Yan, Muhammad Haris, Greg Shakhnarovich, Norimichi Ukita, Shijia Hu, Yijie Bei, Hui Zheng, Jiang Xiao, Yanan Gu, Jie Liu, Yifan Wang, Federico Perazzi, Brian McWilliams, Alexander Sorkine‐Hornung, Olga Sorkine‐Hornung, Christopher Schroers, Jiahui Yu, Yuchen Fan, Jianchao Yang, Ning Xu, Zhaowen Wang, Xinchao Wang, Thomas S. Huang, Xintao Wang, Ke Yu, Tak-Wai Hui, Chao Dong, Liang Lin, Chen Change Loy, Park Dongwon, Kwanyoung Kim, Se Young Chun, Kai Zhang, Pengjv Liu, Wangmeng Zuo, Shi Guo, Jiye Liu, Jinchang Xu, YI-JIAO LIU, Fengye Xiong, Yuan Dong, Hongliang Bai, Alexandru Damian, Nikhil Ravi, Sachit Menon, Cynthia Rudin, Junghoon Seo, Taegyun Jeon, Jamyoung Koo, Seunghyun Jeon, Soo Ye Kim, Jae-Seok Choi, Sehwan Ki, Soomin Seo, Hyeonjun Sim, Saehun Kim, Munchurl Kim, Rong Chen, Kun Zeng, Jinkang Guo, Yanyun Qu, Cuihua Li, Namhyuk Ahn, Byungkon Kang, Kyung-Ah Sohn, Yuan Yuan, Jiawei Zhang, Jiahao Pang, Xiangyu Xu, Yan Zhao, Wei Deng, Sibt ul Hussain, Muneeb Aadil, Rafia Rahim, Xiaowang Cai, Fang Huang, Yueshu Xu, Pablo Navarrete Michelini, Dan Zhu, Hanwen Liu, Jun-Hyuk Kim, Jong‐Seok Lee, Yi‐Wen Huang, Ming Qiu, Liting Jing, Jiehang Zeng, Ying Wang, Manoj Sharma, Rudrabha Mukhopadhyay, Avinash Upadhyay, Sriharsha Koundinya, Ankit Shukla, Santanu Chaudhury, Zhe Zhang, Yu Hen Hu and 1 more - IEEE/CVF Conference on Computer Vision and Pattern Recognition Workshops (CVPRW), CVPR Workshops 2018 cited by 372

  20. Osimertinib in Patients With Epidermal Growth Factor Receptor Mutation–Positive Non–Small-Cell Lung Cancer and Leptomeningeal Metastases: The BLOOM Study

    Authors: James Chih‐Hsin Yang, Sang-We Kim, Dong‐Wan Kim, Jong Seok Lee, Byoung Chul Cho, Jin-Seok Ahn, Dae H. Lee, Tae Min Kim, Jonathan W. Goldman, Ronald B. Natale, Andy Brown, Barbara Collins, Juliann Chmielecki, Karthick Vishwanathan, Ariadna Mendoza‐Naranjo, Myung‐Ju Ahn - Journal of Clinical Oncology 2019 cited by 397

  21. PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer

    Authors: Yoon‐Koo Kang, Jeong Hwan Yook, Young-Kyu Park, Jong Seok Lee, Young‐Woo Kim, Jin Young Kim, Min‐Hee Ryu, Sun Young Rha, Ik‐Joo Chung, In‐Ho Kim, Sang Cheul Oh, Young Soo Park, Taeil Son, Mi Ran Jung, Mi Hwa Heo, Hark Kyun Kim, Cho‐Hyun Park, Chang Hak Yoo, Jin‐Hyuk Choi, Dae Young Zang, You Jin Jang, Ji Young Sul, Jong Gwang Kim, Beom Su Kim, Seung‐Hoon Beom, Sang‐Hee Cho, Seung Wan Ryu, Myeong‐Cherl Kook, Baek‐Yeol Ryoo, Hyun Ki Kim, Moon‐Won Yoo, Nam Su Lee, Sang Ho Lee, Gyunji Kim, YeonJu Lee, Jee Hyun Lee, Sung Hoon Noh - Journal of Clinical Oncology 2021 cited by 355

  22. Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410

    Authors: Walter J. Curran, Rebecca Paulus, Corey J. Langer, R. Komaki, Jong Seok Lee, Stephen L. Hauser, B. Movsas, Todd H. Wasserman, Seth A. Rosenthal, Elizabeth Gore, Mitchell Machtay, William T. Sause, James D. Cox - JNCI Journal of the National Cancer Institute 2011 cited by 1,235

  23. Osimertinib plus savolitinib in patients with EGFR mutation-positive, MET-amplified, non-small-cell lung cancer after progression on EGFR tyrosine kinase inhibitors: interim results from a multicentre, open-label, phase 1b study

    Authors: Lecia V. Sequist, Ji‐Youn Han, Myung‐Ju Ahn, Byoung Chul Cho, Helena A. Yu, Sang-We Kim, James Chih‐Hsin Yang, Jong Seok Lee, Wu‐Chou Su, Dariusz M. Kowalski, Sergey Orlov, Mireille Cantarini, Remy B. Verheijen, Anders Mellemgaard, Lone H. Ottesen, Paul Frewer, Xiaoling Ou, Geoffrey R. Oxnard - The Lancet Oncology 2020 cited by 413

  24. Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451

    Authors: Taofeek K. Owonikoko, Keunchil Park, Ramaswamy Govindan, Neal Ready, Martin Reck, Solange Peters, Shaker R. Dakhil, Alejandro Navarro, Jerónimo Rafael Rodríguez‐Cid, Michael Schenker, Jong Seok Lee, Vanesa Gutiérrez, Ivor Percent, Daniel Morgensztern, Carlos H. Barrios, Laurent Greillier, Sofia Baka, Miten Patel, Wen Lin, Giovanni Selvaggi, Christine Baudelet, Jonathan Baden, Dimple Pandya, Parul Doshi, Hye Ryun Kim - Journal of Clinical Oncology 2021 cited by 267